Myteka Tablet Uses

Myteka tablet is used for the prevention and treatment of asthma, seasonal allergies, and chronic obstructive pulmonary disease (COPD). It belongs to a class of drugs known as leukotriene modifiers in the body. Following are some common uses of the Myteka Tablet:

1. Asthma: Myteka tablet is commonly used for the long-term treatment of asthma in adults and children above the age of 12. It helps to control and prevent symptoms such as wheezing, shortness of breath, coughing, and chest tightness.
2. Allergic Rhinitis: Myteka tablet is also used for the relief of symptoms related to allergic rhinitis, including sneezing, itching, runny nose, and nasal congestion.
3. Exercise-Induced Bronchoconstriction (EIB): Myteka is sometimes used to prevent breathing difficulties caused by exercise in people with asthma or EIB. It helps reduce the narrowing of airways that can occur during exercise.

Off-Label Uses of Myteka Tablet

1. Eosinophilic Esophagitis (EoE): Myteka tablet has been used off-label as part of the treatment regimen for EoE in some cases. It is a chronic immune-mediated disorder of the esophagus characterized by eosinophilic inflammation.
2. Allergic Bronchopulmonary Aspergillosis (ABPA): Myteka tablet has been used off-label in some cases as an adjunctive treatment to corticosteroids to help manage the symptoms of ABPA. It is a hypersensitivity reaction to the fungus Aspergillus fumigatus in the airways, primarily affecting individuals with asthma or cystic fibrosis.
3. Urticaria (Hives): Myteka tablet has been used off-label in the treatment of chronic idiopathic urticaria (CIU) or chronic spontaneous urticaria (CSU). It is a condition characterized by recurring hives or wheals of unknown cause that last for at least six weeks.

Myteka is one of the leading brands of Montelukast Sodium, manufactured and marketed by Hilton Pharma Pakistan.

Following are some alternative brands of Myteka and their manufacturers.

• Montiget : Getz Pharmaceuticals, Pakistan.
• Montika : Sami Pharmaceuticals (Pvt) Ltd.
• Freehale : High-Q Pharmaceuticals, Pakistan.
• Aerotel : Highnoon Laboratories (Pvt) Ltd.
• Aireez : PharmEvo (Pvt) Ltd.
• Amisped : Sanofi Aventis (Pakistan) Ltd.
• Beasy : Bosch Pharmaceuticals (Pvt) Ltd.
• Bronsecur : Pfizer Laboratories (Pvt) Ltd.
• Inspra : Martin Dow Pharmaceuticals (Pvt) Ltd.
• Montelo : Novartis Pharma Pakistan (Pvt) Ltd.

Presently, Myteka is available in Tablet and Sachet Forms.

Myteka Tablets : 4mg, 5mg & 10mg Tablets

Sachet (Powder form) : 4mg Sachet

Although Myteka is an effective medicine, still there are some important contraindications that should be considered before using Myteka tablet.

Hypersensitivity: Myteka is contraindicated in individuals who have a known hypersensitivity or allergy to the active ingredient, Myteka sodium, or any other components of the medication.

Acute Asthma Attack: Myteka should not be used to treat acute asthma attacks. It is not intended for immediate relief of sudden or severe asthma symptoms. Short-acting bronchodilators, such as albuterol, are typically used to manage acute asthma attacks.

Severe Hepatic Impairment: Myteka is contraindicated in individuals with severe hepatic impairment. The dosage of Myteka may need to be adjusted or an alternative treatment considered for patients with moderate hepatic impairment.

Phenylketonuria (PKU): Some formulations of Myteka contain aspartame, which is a source of phenylalanine. Individuals with phenylketonuria, a rare genetic disorder that affects the metabolism of phenylalanine, should be cautious and consult with their healthcare provider before using Myteka products containing aspartame.

Additionally, pregnant women or women who are breastfeeding should discuss their options carefully with their doctor before deciding on this treatment plan.

Myteka is taken orally, usually once daily.

The recommended dose for adults is 10mg tablet per day; however, doses may be adjusted depending on individual needs.

For those 15 years old or older, a 10mg tablet is usually prescribed.

For children aged 6 to 14 years old, the recommended dose is 5mg tablet per day.

Myteka works quickly but may take up to several weeks before full effects are seen; therefore, it must be used consistently for the best results.

Myteka is an oral leukotriene receptor antagonist, that works by binding to cysteinyl leukotriene (cysLT) receptors on cells located throughout the body, particularly within respiratory tissues, preventing cysLTs from binding to them and triggering an inflammatory response. This prevents bronchoconstriction and other symptoms that are associated with asthma or allergies.

Myteka also helps reduce airway inflammation by decreasing specific pro-inflammatory mediators such as prostaglandins and cytokines which can contribute to worsening symptoms over time if left untreated.

Related Links:

Myteka Side Effects